Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Emery

Showing results (21-30 of 731) with videos related to

Pageof 74
Sort By:
Discovery Medicine|October 15, 2015
Is localized autoimmunity the trigger for rheumatoid arthritis? Unravelling new targets for preventionKulveer Mankia, Paul Emery
Annals of the Rheumatic Diseases|August 12, 2010
The American College of Rheumatology/European League Against Rheumatism Criteria for the classification of rheumatoid arthritis: a game changerStanley Cohen, Paul Emery
Nature Reviews. Rheumatology|June 18, 2014
Defining populations at risk of rheumatoid arthritis: the first steps to preventionLaura Hunt, Paul Emery
Expert Opinion on Biological Therapy|August 2, 2012
The role of tocilizumab in the management of rheumatoid arthritisZoe Ash, Paul Emery
International Journal of Rheumatic Diseases|May 3, 2021
Should we aim for personalized prevention in individuals at risk of rheumatoid arthritis?Kulveer Mankia, Paul Emery
Skeletal Radiology|September 6, 2008
Rheumatoid arthritis: what has changed?Edith Villeneuve, Paul Emery
The Lancet. Rheumatology|January 26, 2024
It's never too soon to treat rheumatoid arthritis: finally, some supportive evidencePaul Emery, Laurence Duquenne
Annals of Medicine|January 20, 2011
Golimumab - a new tool in the armoury against inflammatory arthritisZoe Ash, Paul Emery
Annals of the Rheumatic Diseases|March 2, 2017
Imminent rheumatoid arthritis can be identified in primary careKulveer Mankia, Paul Emery
BMJ (Clinical Research Ed.)|February 9, 2002
Treating rheumatoid arthritis with tumour necrosis factor alpha blockadePaul Emery, Maya Buch
Pageof 74

Showing results (21-30 of 731) with videos related to

Sort By:
Pageof 74
Discovery Medicine|October 15, 2015
Is localized autoimmunity the trigger for rheumatoid arthritis? Unravelling new targets for preventionKulveer Mankia, Paul Emery
Annals of the Rheumatic Diseases|August 12, 2010
The American College of Rheumatology/European League Against Rheumatism Criteria for the classification of rheumatoid arthritis: a game changerStanley Cohen, Paul Emery
Nature Reviews. Rheumatology|June 18, 2014
Defining populations at risk of rheumatoid arthritis: the first steps to preventionLaura Hunt, Paul Emery
Expert Opinion on Biological Therapy|August 2, 2012
The role of tocilizumab in the management of rheumatoid arthritisZoe Ash, Paul Emery
International Journal of Rheumatic Diseases|May 3, 2021
Should we aim for personalized prevention in individuals at risk of rheumatoid arthritis?Kulveer Mankia, Paul Emery
Skeletal Radiology|September 6, 2008
Rheumatoid arthritis: what has changed?Edith Villeneuve, Paul Emery
The Lancet. Rheumatology|January 26, 2024
It's never too soon to treat rheumatoid arthritis: finally, some supportive evidencePaul Emery, Laurence Duquenne
Annals of Medicine|January 20, 2011
Golimumab - a new tool in the armoury against inflammatory arthritisZoe Ash, Paul Emery
Annals of the Rheumatic Diseases|March 2, 2017
Imminent rheumatoid arthritis can be identified in primary careKulveer Mankia, Paul Emery
BMJ (Clinical Research Ed.)|February 9, 2002
Treating rheumatoid arthritis with tumour necrosis factor alpha blockadePaul Emery, Maya Buch
Pageof 74